Author

D. Y. Wang

Cornell University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

J. J. H. Chu· 2 shared K. S. Tan· 2 shared Alexander Yu. NikitiniD· 1 shared Andrea Flesken‐NikitiniD· 1 shared Andrew K. GodwiniD· 1 shared Anna V. YemelyanovaiD· 1 shared B. A. Ahidjo· 1 shared B. Burt· 1 shared

Activity by Year

2020-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. J. H. Chu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation

Coulter Q. Ralston, Andrea Flesken‐Nikitin, Dah‐Jiun Fu, Christopher S. Ashe, Blaine A. Harlan, M. Mozammal Hossain, D. Y. Wang, Anna V. Yemelyanova, Elisa Schmoeckel, Andrew K. Godwin, Doris Cooper Mayr, Benjamin D. Cosgrove, Alexander Yu. Nikitin

The paper compares single-cell transcriptomes of mouse and human tubal epithelium to show injury-driven regeneration in humans may contribute to ovarian cancer initiation.

bioRxiv · Mar 30, 2026 · PreprintCancer Biology

Inhibition of CDK4/6 Overcomes Primary Resistance to PD-1 Blockade in Malignant Mesothelioma

H.-J. Jang, C. Y. Truong, E. M. Lo, H. M. Holmes, D. Ramos, M. Ramineni, J.-S. Lee, D. Y. Wang, M. Pietropaolo, R. T. Ripley, B. Burt, H.-S. Lee

This study identifies CDK4/6 as a therapeutic target to overcome primary resistance to PD-1 blockade in malignant mesothelioma by analyzing genomic and immunogenomic data.

bioRxiv · Mar 4, 2021Immunology

Direct cleavage of human NLRP1 by enteroviral 3C protease triggers inflammasome activation in airway epithelium

K. Robinson, D. E. T. Teo, K. S. Tan, G. A. Toh, H. H. Ong, C. K. Lim, K. Lay, B. V. Au, T. S. Lew, J. J. H. Chu, V. T. K. Chow, D. Y. Wang, F. L. Zhong, B. Reversade

The paper identifies enteroviral 3C proteases as the first cognate PAMP ligand for human NLRP1, showing they trigger inflammasome activation and airway inflammation.

bioRxiv · Oct 14, 2020 · PreprintImmunology

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

C. K. Mok, Y. L. Ng, B. A. Ahidjo, R. C. H. Lee, M. W. C. Loe, J. Liu, K. S. Tan, P. Kaur, W. J. Chng, J. E. L. Wong, D. Y. Wang, E. W. Hao, X. Hao, Y. W. Tan, T. M. Mak, , J. J. H. Chu

This study identifies calcitriol, the active form of vitamin D, as a potent inhibitor of SARS-CoV-2, suggesting its potential as a prophylactic agent against COVID-19.

bioRxiv · Jun 21, 2020 · PreprintMicrobiology